Open access
Sep 2026
Clinical outcomes and their relationship with tigecycline exposure in critically ill patients with drug resistant infections
Background Dosing tigecycline, an important last resort for carbapenem-resistant organisms, should be under the guidance of pharmacokinetic/pharmacodynamic (PK/PD) theory. However, tigecycline has shown large interindividual variability in PK among different patients, and its PK/PD target has limited data support. This...
Wei Su, Shu-Ping Song, Qing Tang et al.
· Frontiers in Cellular and In... · 0 citations